!!Projects per year
Perfil de la organización
Organization profile
For more than 40 years, the Markey Cancer Center has served the Commonwealth of Kentucky and is an integral part of the University of Kentucky and UK HealthCare. Markey is the only NCI-designated cancer center in Kentucky, and one of only a handful in the country. In addition, Markey Cancer Center has been listed in U.S. News and World Reports Top 50 Cancer Centers for the past three years.
The Markey Cancer Center was first designated by the National Cancer Institute in 2013 – a distinction that recognizes its extraordinary ability to conduct world-class research, launch ground-breaking clinical trials, and provide exceptional patient care. NCI-designated centers are a major source of discovery and development in the fight against cancer.
Membership in the Markey Cancer Center research community consists of investigators from across the university who have demonstrated scientific excellence and their commitment to collaborative work in cancer research. Each investigator works within one of three thematic research programs:
- Cancer Prevention and Control (CP)
- Molecular and Cellular Oncology (MCO)
- Translational Oncology (TO).
Additionally, Markey has established five shared resource facilities: Biospecimen Procurement and Translational Pathology (BPTP), Redox Metabolism (RM), Biostatistics and Bioinformatics (BB), Cancer Research Informatics (CRI), and Flow Cytometry and Immune Monitoring (FCIM); with two additional facilities under development: Patient-oriented and Population Sciences (POP) and Oncogenomics (OG), to aid researchers in their work.
For more information and resources, visit the Markey Cancer Center website.
Huella digital
Colaboraciones y áreas de investigación principales de los últimos cinco años
Unidades de investigación
-
Cancer Prevention and Control Research Program
Markey Cancer Center / Cancer Research Priority Initiative
Unidad organizativa: Department
-
Molecular and Cellular Oncology Research Program
Markey Cancer Center / Cancer Research Priority Initiative
Unidad organizativa: Department
-
Translational Oncology Research Program
Markey Cancer Center / Cancer Research Priority Initiative
Unidad organizativa: Department
Perfiles
-
Olufunmilola Abraham, Ph.D.
- Pharmacy Practice and Science - Professor, Chair, Pharmacy Practice and Science, US Surgical Endowed Professor
- Cancer Prevention and Control Research Program - Member
- Center for Health, Engagement, and Transformation (CHET) - Core Faculty
- Markey Cancer Center / Cancer Research Priority Initiative - Member
- UNITE Research Priority Area
Persona
-
Val Adams, Pharm.D
- Pharmacy Practice and Science - Associate Professor
- Internal Medicine - Joint Appointment
- Markey Cancer Center / Cancer Research Priority Initiative - Member
- Translational Oncology Research Program - Member
Persona
-
Adebola Adegboyega, Ph.D.
- College of Nursing - Associate Professor
- Cancer Prevention and Control Research Program - Member
- Center for Health, Engagement, and Transformation (CHET) - Core Faculty
- Markey Cancer Center / Cancer Research Priority Initiative - Member
- UNITE Research Priority Area
Persona
-
FY27 ABL and Pediatric Glioma
Plattner, R. (PI), Lightner, D. (CoI), Munnikhuysen, S. (CoI), Neltner, J. (CoI), Thibault, O. (CoI) & Wang, C. (CoI)
KY Cabinet for Health and Family Services
7/1/26 → 6/30/28
Proyecto: Research project
-
FY27 Colon Cancer Screening Services - Program Period 26 (August 30th - June 30th, 2027)
Knight, J. (PI)
KY Cabinet for Health and Family Services
7/1/26 → 6/30/28
Proyecto: Research project
Producción científica
-
503: QUALITY OF COMMUNICATION IN FAMILY MEETINGS PREDICTS POST-MEETING ICU LENGTH OF STAY
Scott, A., Chinchilli, V., Costigan, H., Deng, D., Groznik, M., Huang, Y., Kimbel, K., Kitko, L., Ribott, M., VanDyke, E., Wasserman, E., White, D. & Van Scoy, L., mar 2026, En: Critical Care Medicine. 54, 3SProducción científica: Article › revisión exhaustiva
-
6-Phosphogluconate dehydrogenase promotes mitochondrial fusion and immune suppression in tumor-associated monocytic suppressor cells
Daneshmandi, S., Yan, Q., Gomez, E. C., Choi, J. E., Katsuta, E., Gharib, E., Singh, P. K., Higashi, R. M., Lane, A. N., Fan, T. W. M., Wang, J., Repasky, E. A., McCarthy, P. L. & Mohammadpour, H., dic 2026, En: Nature Communications. 17, 1, 229.Producción científica: Article › revisión exhaustiva
Acceso abierto1 Cita (Scopus) -
703: CERAMIDE AS A NOVEL BIOMARKER IN ACUTE RESPIRATORY DISTRESS SYNDROME
McKinney, L., Morris, P., Allegood, J. & Sturgill, J., mar 2026, En: Critical Care Medicine. 54, 3SProducción científica: Article › revisión exhaustiva
Premios
-
-
-
Medical Student Rotation Award for Underrepresented Populations
Bernard, M. (Recipient), 2011
Premio: Honorary award
Actividades
-
-
Rural and Urban Differences in African American Cocaine Users’ Preferred Treatment Sites and Types
Borders, T. (Speaker)
oct 1 2013Actividad: Oral presentation
-
Community-Academic Partnerships for Environmental Health in Appalachia- Building Blocks of Positive Change
Stanifer, S. (Speaker)
oct 1 2021Actividad: Oral presentation